← Back to All Filings

UNH Director Acquires Shares via Dividend Equivalents

Low SignificanceDecember 18, 2025 at 5:36:53 PM EST

UNITEDHEALTH GROUP INC

$UNH4CIK: 0000731766

Subscribe to track UNH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

UNH Director Acquires Shares via Dividend Equivalents

Company: UNITEDHEALTH GROUP INC (UNH) Form: 4 | Filed: 2025-12-18 Significance: Low

Insider: GARCIA PAUL R Title: null | Relationship: Director

Transaction: • Type: Grant (Dividend Equivalent) • Shares: 13 • Price: $0.00 • Value: $0 • Owned After: 3,034 (Direct)

Key Insight: This is a routine, non-cash acquisition of dividend equivalents on previously granted stock units, representing an immaterial change in holdings.

Market Context: The transaction is negligible for a mega-cap company like UnitedHealth Group and has no market impact.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: UNITEDHEALTH GROUP INC (UNH)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director acquired a nominal number of shares as dividend equivalents on existing deferred stock units, a routine and non-market event.
  • Market Impact: None. The transaction is administrative and has zero monetary value.

Company Information

FieldValue
CompanyUNITEDHEALTH GROUP INC
Ticker SymbolUNH
CIK0000731766
IndustryHospital & Medical Service Plans

Insider Information

FieldValue
NameGARCIA PAUL R
CIK0001226012
Title/Positionnull
RelationshipDirector

Transaction Details

FieldValue
Form Type4
Transaction Date2025-12-16
Transaction CodeA (Award)
Security TypeCommon Stock
Shares Involved13
Price Per Share$0.00
Total Value$0
Shares Owned After3,034 (Directly)
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$0
% of Market Cap0.00%
Shares Transacted13
% of Shares Outstanding<0.00001%
Post-Transaction Ownership5,280 shares (Direct & Indirect) (approx. 0.00058% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $291.55 billion, this $0 transaction is entirely immaterial.
  • Ownership Concentration: The insider's total holdings of 5,280 shares represent a negligible fraction of the 905.7 million shares outstanding.
  • Dilution Impact: Not applicable as this is not a new issuance from the treasury but a dividend equivalent on existing units.
  • Transaction Significance: The transaction is administrative, reflecting the reinvestment of dividends on vested stock units, and carries no investment signal.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: This is a non-market, zero-value transaction with no cash outlay by the insider. It does not reflect any new investment decision.

Volume & Sentiment

  • Expected Volume Impact: None. The transaction did not occur on the open market.
  • Sentiment Indicator: Neutral. The filing is procedural and provides no new information to influence market sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: As per Footnote 1, the shares represent "dividend equivalents paid on vested deferred stock units." These are automatically granted and immediately vested, making this a passive acquisition.
Topics:#SECFiling#InsiderTrading#UNH#UnitedHealth#Form4#StockMarket#Investing#Finance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.